Nuuron

Revolutionizing Alzheimer’s care through a breakthrough digital-photonic neuromodulation therapy.

Nuuron is developing a fully digital Alzheimer's therapy based on proprietary neuromodulation technology. Nuuron's algorithms produce ultra-high frequency, digital-photonic stimuli that activate the memory center of Alzheimer's patients to improve information storage and retrieval. For this digital disease-modifying therapy, Nuuron uses the retina as a computer-brain interface using state-of-the-art VR and AR technologies.
investment manager
co-investors
HTGF, caesar., Business Angel Club Berlin, Business Angels, Family Offices
invested since
2024
website
social media